[Refractory arterial hypertension].
The present review synthesizes "the state of the art" concerning resistant (refractory) arterial hypertension (RAH). Definition, epidemiology, frequent risk factors, clinical conditions and causes of therapeutic resistance of RAH are revisited. Pathogenic hypothesis and related therapeutic approaches are explored. The paper lists current and new pharmacological therapies of RAH and introduces the latest interventional approach (the Rheos BHT system) to this form of arterial hypertension.
Antohe
Ileana
I
Universitatea de Medicină si Farmacie Gr T Popa Iaşi, Facultatea de Medicină.
D000959:Antihypertensive Agents / Q000627:therapeutic use; D017704:Baroreflex; D019917:Blood Vessel Prosthesis Implantation / Q000379:methods*; D002986:Clinical Trials as Topic; D004351:Drug Resistance; D006801:Humans; D006974:Hypertension, Malignant / Q000188:drug therapy / Q000503:physiopathology* / Q000601:surgery*; D008019:Life Style; D010349:Patient Compliance; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D016896:Treatment Outcome
D000959:Antihypertensive Agents